A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial Protocol
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
More News: Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Heart | Hepatocellular Carcinoma | Liver Cancer | Radiology